Loading…
Held by equity mutual funds in 158 disclosed months, Nov 2012 to Sep 2026.
Procter & Gamble Health Limited (Pharmaceuticals & Biotechnology) was held by 18 active equity mutual funds in September 2026, ₹423 Cr in all (down 1 fund from Aug 2026). The largest position was UTI - MNC Fund at 4.0% of its portfolio. During the month 0 funds entered and 1 exited. Funds have disclosed holding it since Nov 2012.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
How many equity funds held the company each month, and the value they held.